Patents/Assignees

Fred Hutchinson Cancer Center

58 patents in portfolio

US11879018utility2024
Circular Tandem Repeat Proteins
0 cites
US11872195utility2024
Compositions and Methods to Program Therapeutic Cells Using Targeted Nucleic Acid Nanocarriers
0 cites
US11860164utility2024
Markers, Methods and Systems for Identifying Cell Populations, Diagnosing, Monitoring, Predicting and Treating Conditions
0 cites
US11845803utility2023
Combination Therapies for Treatment of Bcma-related Cancers and Autoimmune Disorders
0 cites
US11834511utility2023
Compositions and Methods for CD20 Immunotherapy
0 cites
US11827904utility2023
Modified Stem Cells and Uses Thereof
0 cites
US11821111utility2023
Barcoded Influenza Viruses and Deep Mutational Scanning Libraries Including the Same
0 cites
US11786557utility2023
Luteinizing Hormone Receptor Binding Agents and Luteinizing Hormone Agonists to Identify, Expand, Ablate and Modify Stem Cells
0 cites
US11744843utility2023
Identification and Treatment of T-cell Epitopes of Short H2A Oncohistones
0 cites
US11733248utility2023
High Efficiency Targeted in Situ Genome-wide Profiling
0 cites
US11723962utility2023
Cell-based Neoantigen Vaccines and Uses Thereof
0 cites
US11725210utility2023
Immunomodulatory Fusion Proteins and Uses Thereof
0 cites
US11718875utility2023
Compositions and Methods for Detecting Allogeneic Matter in a Subject
0 cites
US11718876utility2023
Compositions and Methods for Detecting Allogeneic Matter in a Subject
0 cites
US11603544utility2023
Genomic Safe Harbors for Genetic Therapies in Human Stem Cells and Engineered Nanoparticles to Provide Targeted Genetic Therapies
0 cites
US11578118utility2023
Systems and Methods to Produce B Cells Genetically Modified to Express Selected Antibodies
0 cites
US11566061utility2023
Systems and Methods to Improve Vaccine Efficacy
0 cites
US11548923utility2023
Peptide Compositions and Methods of Use Thereof for Disrupting TEAD Interactions
0 cites

← PreviousPage 3 of 3